CARLSBAD, Calif., Jan. 6 AutoGenomics, a leader in providing automated, molecular testing solutions, announced today that the company has been invited and has accepted to present at the JPMorgan Healthcare Conference, which will be held January 12-15, 2009 at the Westin St. Francis Hotel in San Francisco, CA. At this conference, Fareed Kureshy, President & CEO will provide an overview of the Company at 11:00am on Tuesday, January 13, 2009.
About JPMorgan 27th Annual Healthcare Conference: JPMorgan's premier annual conference on the healthcare industry will feature more than 300 public and private companies over four days of simultaneous sessions.
AutoGenomics Inc., a privately held company based in Carlsbad, CA, has developed an automated, microarray based multiplexing diagnostic platform that can be used to assess disease signatures with novel genomic and proteomic markers in the area of genetic disorders, infectious disease, cancer and pharmacogenetics. With the discovery of genes and their link to various disease states the platform has the versatility to revolutionize the way patients are diagnosed, monitored and managed leading to the era of personalized medicine. www.autogenomics.com
SOURCE AutoGenomics Inc.